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We studied the recognition of, interest in, and understanding of induced pluripotent stem (iPS) cells and
regenerative medicine in a total of 2659 junior high school, senior high school, and university students.
The number of valid responses received was 2396 (90.1%). We report the following seven observations
[1]. More than 80% of students reported recognition of iPS cells, regenerative medicine, and Professor
Shinya Yamanaka, and a similar number were interested in and supportive of regenerative medicine [2].
Regenerative medicine was viewed as a medical treatment option. However, females were more cautious
regarding use of regenerative medicine as a treatment compared with males [3]. Approximately 90% of
students were interested in the latest medical care. Among the new treatment methods, they more
frequently selected those that they were more familiar with and perceived less invasive to be ideal [4].
Regarding organ or tissue donation in regenerative medicine, students focused more on the character-
istics of the donors [5]. Approximately 90% were supportive of storing their own cells. However,
approximately 50% of students supported storing iPS cells for use in regenerative medicine [6]. Most
students were anxious regarding the side effects, safety, and treatment costs of regenerative medicine,
but supported the need of education regarding regenerative medicine [7]. More than 70% of students
thought that education of regenerative medicine was necessary for the public. These ﬁndings suggest the
importance of social approach, in addition to medical approach such as research and development, to
improve QOL in community by developing the public understanding of regenerative medicine through
science communication and school education, for the establishment of systems to promote this ﬁeld.
© 2016, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Induced pluripotent stem (iPS) cells were ﬁrst reported after the
reprogramming of mouse ﬁbroblasts in 2006, and human ﬁbro-
blasts in 2007 [1e3]. The cells were originally generated by intro-
duction of the OCT3/4, SOX2, KLF4, and c-MYC genes by a retrovirus
[1]. More effective experimental procedures have since been
developed to obtain iPS cells from somatic cells by expression ofnce, Course for School Nurse
1 Bunkyo, Mito, Ibaraki 310-
(K. Ishihara).
se Society for Regenerative
ative Medicine. Production and hovarious combinations of transcription factors or by addition of
chemical compounds [3e12]. Professor Shinya Yamanaka, director
of the Center for iPS Cell Research and Application (CiRA) in Kyoto
University, won the Nobel Prize in Physiology or Medicine in 2012,
by his series of such studies.
Stem cells, which include somatic stem cells such as hemato-
poietic cells, embryonic stem (ES) cells, and iPS cells, have both self-
renewal capability and ability to give rise to differentiated cell lines
[13,14]. Tissue homeostasis is maintained via the self-renewal and
differentiation of somatic stem cells. Especially, hematopoietic
stem cells can enter the cell cycle and either self-renew or differ-
entiate into multipotent progenitors that provide diverse mature
blood cells [15]. On the other hand, ES cells that obtain from inner
cell mass of mammalian embryos in blastocyst stage, have been
reported to be established in mouse in 1981 [16,17] and human in
1998 [18]. The capacity for unlimited growth and potential tosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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suggested the possibility for cell transplantation therapy, drug
screening or toxicity by using patient-speciﬁc differentiated cells.
However, as for organ transplants, tissue rejection remains a
signiﬁcant concern for ES cell transplantation. Another concern is
the use of human embryos [19]. Therefore, establishment of iPS
cells in human in 2007 promoted regenerative medicine due to the
resolve of the ethical problems of ES cells. The great efforts of the
researchers have found possibility of the transplantation therapy
with stem cells. QOL of patients is about to improvement by these
medical approach.
iPS cells theoretically possess the ability to differentiate into any
type of cell allowing construction of various tissues and organs, and
have the advantage of being able to be prepared using somatic cells
collected directly from the patient. iPS cells provide the opportu-
nity for widespread application, not only limited to cell
transplantation therapy, but also for disease modeling in vitro for
investigation of pathogenesis and drug screening for novel medi-
cations [19e21]. Therefore, multilateral studies, including prepa-
ration of tissues and organs, construction of iPS cell stocks for
transplantation, as well as basic studies of the reprogramming
mechanism for iPS cells from somatic cells, were started all over the
world. In Japan, the Ministry of Education, Culture, Sports, Science
and Technology-Japan (MEXT) has started various projects for the
realization of regenerative medicine using iPS cells from 2007
[22,23]. In 2014, clinical research on age-related macular degener-
ation using patient iPS cell-derived retinal pigment epithelial cells
was started by Dr. Masayo Takahashi's team [24,25]. Although ﬁ-
broblasts were originally used the somatic cells for the preparation
of iPS cells [1e3], modiﬁed methods utilizing while blood cells [11]
and a feeder-free culture system [12] have been established for use
in medical treatment. The construction of medical iPS cells stocks
was discussed among the Ministry of Health, Labour and Welfare
(MHLW) [26], CiRA, and the Japanese Red Cross Society, and these
organizations have begun to cooperate in its construction. For
transplantation of an organ or tissue, it is necessary to at least
partially match the human leukocyte antigen (HLA) between the
donor and recipient to reduce the incidence of graft rejection; three
loci, HLA-A, -B, and DR, are important for this process [27,28]. Okita
et al. estimated that the establishment of 140 HLA-homozygous
lines for iPS cells selected from 160,000 individuals would pro-
vide a match for 90% of the Japanese population [10]. Therefore, the
understanding and cooperation of the Japanese public for the
construction of such an iPS cell stock is essential.
Recently, importance of science communication is pointed out.
After nuclear power disaster in Fukushima, communication gap
among scientists, media, and the public was indicated [29,30], and
then Horiguchi suggested that training for the skill improvement is
essential in the risk communication among them [30]. Concerning
iPS cells and regenerative medicine, on the other hand, the area of
interest about iPS cells differs among scientists, media, and the
public [31], and Hatta has mentioned there is a gap in ability of the
regenerative medicine and social expectation [32]. It seems to be
insufﬁcient that our public has an individual opinion through sci-
ence communication and education, although 10 years are going to
pass since the establishment of iPS cells. The knowledge about the
regenerative medicine of the public was based on information
obtained from the media particularly TV [33,34]. Although, the
public thought to be familiar with the terms iPS cells and regen-
erative medicine, they decided to adopt a “wait and see” approach
[34]. In this survey [34], the number of responders younger than 20
years old who are essentially the stakeholders of such a technology
when regenerative medicine is realized, was remarkably low,
because it was targeted tomembers of a particular company as well
as newspaper readers. Therefore, it is remained to be elucidatedhow the Japanese students feel about iPS cells and regenerative
medicine. By medical approach, which is effort of researchers in
research and development such as establishment of ES cells and iPS
cells, and laboratory to clinical research, regenerative medicine
might realize as one of the medical cares in future. Therefore, social
approach, which is the public understanding of regenerative
medicine through science communication and school education to
construct better medical care with medical approach, plays critical
roles for the realization. Thus, they are important for us to under-
stand science knowledge and technical terms for regenerative
medicine through them, and then to construct better medical care
with medical approach, or to be able to understand the medical
care when we receive it. Such social approach to improve con-
sciousness of the public might be necessary for realization of
regenerative medicine together with medical approach.
Therefore, in the present study, we investigated the recognition
of, interest in, and understanding of iPS cells and regenerative
medicine in junior high school, senior high school, and university
students.2. Methods
2.1. Participants
Participants were 2659 students at ﬁve junior high schools, two
high schools, and ﬁve universities. The number of valid responses
received was 2396 (male: n ¼ 967, female: n ¼ 1429) (junior high
school: n ¼ 724, high school n ¼ 866, university n ¼ 806) with a
valid responses rate of 90.1%. This study applies judgmental
sampling design. We asked principal and faculty to perform ques-
tionnaire by mail. The school and faculty which obtained its con-
sent were qualiﬁed in the sex ratio of pupils, a scale of the class, and
achievement level of pupils. Students in schools that obtained
consent from principal and faculty, ﬁlled out a questionnaire.
Numbers of participants in each school depended on the circum-
stance. Because numbers of participants among kind of schools
adjusted almost same, numbers of schools in kind of schools has
been different. The survey was conducted between October and
November 2013 under the supervision of classroom teachers in
each school.2.2. Questionnaire
The questionnaire contained 19 questions covering the
following 5 categories: (1) background of responder, (2) recogni-
tion of iPS cells and regenerative medicine, (3) future medical
development, (4) relationship between the public and regenerative
medicine, and (5) education for regenerative medicine (Table 1).2.3. Statistical analysis
SPSS statistics version 20 (IBM Japan, Tokyo) was used for sta-
tistical analysis. Pearson's chi-square test was used to compare
differences with respect to sex and kind of school.2.4. Ethical consideration
We explained the purpose of this research to the principal and
faculty of each junior high school, high school, and university.
Teachers supervising the questionnaire verbally explained to the
students that participationwas anonymous and voluntary, and that
the data would be used only for the purpose of this research.
Table 1
List of questions.
Q1 What is your occupation?
Q2. What is your sex?
Q3. Do you know about iPS cells, regenerative medicine, and the winning of the Nobel Prize by Professor Shinya Yamanaka?
Q4. Are you interested in medicine that transplant tissue and organ prepared from someone's cells?
Q5. Do you believe there is a need for realization of medicine that transplant tissue and organ prepared from someone's cells?
Q6. How would you feel if you were informed by a medical doctor that it was necessary for you to receive a transplant of someone's organ or tissue to save your life?
Q7. How would you feel if you were informed by a medical doctor that it was necessary for you to receive a transplant of someone's organ or tissue to improve your
inconvenient medical condition?
Q8. Are you interested in the development of new medical technologies for incurable diseases?
Q9. What is your ideal treatment, if you suffered from an incurable disease?
Q10. What treatment would you want to receive, if you suffered from an incurable disease?
Q11. Whose cells would you want to receive for treatment if you receive a transplant of an organ or tissue prepared from someone else's cells?
Q12. To what recipient(s) would you agree to provide your cell-derived organ or tissue to?
Q13. Do you want to cryopreserve your own cells to use the cells for disease or accident?
Q14. What do you want to know about iPS cells and regenerative medicine?
Q15. What are your anxieties concerning iPS cells and regenerative medicine?
Q16. Do you expect the establishment of iPS cell and regenerative medicine usage?
Q17. Do you think you will be involved in work with iPS cells or regenerative medicine in the future?
Q18. Do you think that education for the understanding of iPS cells and regenerative medicine is necessary for the public?
Q19. Do you want to undergo education for improving your understanding of iPS cells and regenerative medicine?
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3.1. Recognition of iPS cells, regenerative medicine, and the winning
of the Nobel Prize by Professor Shinya Yamanaka
When students in the junior high schools, high schools, and uni-
versities were asked regarding their recognition of iPS cells, 50.7% of
the participants answered “I know the word and subject matter”,
32.0% answered “I know the word but not the subject matter”, and
12.2% answered “I know theword and subject matter well” (Table 2).
Therefore, 94.9% of the participants knew the word, and 62.9% knew
both word and subject. Recognition of iPS cells signiﬁcantly differed
among the kinds of schools (p < 0.001). Recognition of iPS cells in
males was also signiﬁcantly higher than in females (p < 0.001).
Concerning recognition of regenerative medicine, “I know the word
and subjectmatterwell”, “I know thewordand subjectmatter”, and “I
know the word but not the subject matter” received 8.2%, 42.9%, and
32.3% of total responses, respectively (Table 2). Therefore, 83.4% knewTable 2
Recognition of iPS cells, regenerative medicine and the winning of the Nobel Prize by Pr
Sex (n) Junior high school High school
Male
(374)
Female
(350)
Total
(724)
Male
(311)
Femal
(555)
iPS cells***, ###
I know the word and subject matter
well.
15.0 4.3 9.8 14.5 8.3
I know the word and subject matter. 46.3 36.0 41.3 49.5 54.6
I know the word but not the subject
matter.
30.2 53.1 41.3 28.6 32.4
I don't know it very well. 4.3 2.0 3.2 3.2 2.7
I don't know it at all. 4.3 4.6 4.4 4.2 2.0
Regenerative medicine***, ###
I know the word and subject matter
well.
11.8 4.6 8.3 6.8 5.9
I know the word and subject matter. 39.3 29.4 34.5 44.4 40.9
I know the word but not the subject
matter.
26.2 43.4 34.5 30.2 36.0
I don't know it very well. 14.4 16.9 15.6 12.2 14.1
I don't know it at all. 8.3 5.7 7.0 6.4 3.1
Winning of the Nobel Prize by Prof. Yamanaka**, ###
I know of it well. 46.3 28.9 37.8 43.7 35.9
I know of it. 40.1 54.6 47.1 46.3 55.5
I don't know of it very well. 5.6 8.6 7.0 4.2 4.7
I don't know of it at all. 8.0 8.0 8.0 5.8 4.0
Statistical signiﬁcance: ###p < 0.001; **p < 0.01; ***p < 0.001 vs. sex.the word, and 51.1% of the participants recognized both word and
subject. The proportion of those reporting recognition of regenerative
medicinewas similar to the proportion of those reporting recognition
of iPS cells. Total proportion of those reporting recognition of Pro-
fessor Shinya Yamanaka'swinning of the Nobel Prize in Physiology or
Medicine in 2012 was 88.9% (Table 2).
These ﬁndings demonstrated that more than 80% of students
have recognition of iPS cells, regenerative medicine, and Professor
Shinya Yamanaka. Report of detailed recognition was higher in
males than females, and increased in an age-dependent manner.
3.2. Interest in regenerative medicine and its realization
When the participants were asked regarding their interest in
regenerative medicine, 55.3% of participants answered “I am
interested in regenerative medicine” and 21.2% as “I am very
interested in regenerative medicine” (Fig. 1). Taken together, 76.5%
of participants reported interest in regenerative medicine. Theofessor Shinya Yamanaka (%).
University Sex Total
(2396)
e Total
(866)
Male
(280)
Female
(526)
Total
(806)
Male
(967)
Female
(1429)
10.5 25.0 11.6 16.3 17.7 8.5 12.2
52.8 51.8 59.7 56.9 48.9 51.9 50.7
31.1 20.7 26.8 24.7 27.0 35.4 32.0
2.9 2.1 1.1 1.5 3.3 2.0 2.5
2.8 0.4 0.8 0.6 3.1 2.2 2.5
6.2 19.3 5.5 10.3 12.3 5.5 8.2
42.1 47.1 53.6 51.4 43.2 42.8 42.9
33.9 23.9 31.2 28.7 26.9 36.0 32.3
13.4 8.9 8.7 8.8 12.1 12.8 12.5
4.3 0.7 1.0 0.9 5.5 2.9 4.0
38.7 47.5 33.1 38.1 45.8 33.1 38.2
52.2 45.0 56.3 52.4 43.5 55.6 50.7
4.5 2.9 5.9 4.8 4.3 6.1 5.4
4.6 4.6 4.8 4.7 6.3 5.2 5.7
(%)
21.2 
19.0 
24.4 
28.2 
16.7 
18.6 
55.3 
57.9 
51.6 
60.0 
58.1 
46.8 
20.8 
21.6 
19.5 
10.9 
23.9 
28.0 
2.7 
1.5 
4.4 
0.9 
1.3 
6.5 
0.0  20.0  40.0  60.0  80.0  100.0  
Total (N=2396) 
Femaile (n=1429) 
Male (n=967) 
University (n=806) 
High school (n=866) 
Junior high school (n=724) 
Fig. 1. Interest in regenerative medicine. I am very interested in regenerative medicine (closed), I am interested in regenerative medicine (hatched), I am not very interested in
regenerative medicine (dotted), and I am not interested in regenerative medicine at all (open). Statistical signiﬁcance: p < 0.001 vs. kinds of schools; p < 0.001 vs. sex.
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increased in an age-dependent manner (p < 0.001). Concerning the
need of regenerative medicine realization, “Strongly agree” and
“Agree” were answered by 36.5% and 50.9% of all participants,
respectively (Fig. 2). On the other hand, “Strongly disagree” was
answered by 1.3% of all participants. The need of its realization was
higher in males than females (p < 0.001), and increased in an age-
dependent manner (p < 0.001). Therefore, approximately 80% of
students reported interest in regenerative medicine, and afﬁrmed
the need of regenerative medicine.
3.3. Opinions on treatment by regenerative medicine
We asked the participants their opinion on receiving regen-
erative medicine if they suffered from a deadly or inconvenient36.5 
31.5 
43.8 
39.0 
36.7 
33.4 
0.0  20.0  
Total (N=2396) 
Femaile (n=1429) 
Male (n=967) 
University (n=806) 
High school (n=866) 
Junior high school (n=724) 
Fig. 2. Need of regenerative medicine realization. Strongly agree (closed), agree (hatched),
kinds of schools; p < 0.001 vs. sex.medical condition. As shown in Fig. 3, participants reported that
they would positively receive an explanation from a medical
doctor in the case of a deadly disease (32.1%, A) or to improve an
inconvenient medical condition (32.0%, B). Treatment with an
organ (tissue) prepared from everyone's cells, including their
own, was 27.0% and 25.7%, respectively. However, less than 1% of
the participants answered that they would accept an organ
(tissue) prepared from cells from others, in contrast with use of
their own cells (approximately 20%). Total responses to the use of
regenerative medicine for treatment were similar between
life-threatening and inconvenient medical conditions (p ¼ 0.863,
data not shown). On the other hand, there was signiﬁcant
difference between males and females in each case (p < 0.001).
Regenerative medicine with an organ (tissue) prepared from cells
of everyone was higher in males than females. Females reported(%)
50.9 
56.6 
42.4 
52.5 
52.3 
47.4 
11.4 
11.2 
11.7 
8.2 
9.8 
16.9 
1.3 
0.7 
2.1 
0.4 
1.2 
2.3 
40.0  60.0  80.0  100.0  
disagree (dotted), and strongly disagree (open). Statistical signiﬁcance: p < 0.001 vs.
(A)
(B)
3.3
2.5
4.6
3.1
2.9
4.1
18.7
20.4
16.0
18.1
17.3
20.9
32.1
35.1
27.6
34.4
34.4
26.8
18.7
19.5
17.4
18.1
18.1
19.9
0.3
0.1
0.6
0.1
0.3
0.4
27.0
22.3
33.8
26.2
26.9
27.9
0.0 20.0 40.0 60.0 80.0 100.0
Total (N=2396)
Femaile (n=1429)
Male (n=967)
University (n=806)
High school (n=866)
Junior high school (n=724)
(%)
3.0
2.2
4.1
2.1
2.4
4.7
17.9
20.8
13.7
18.0
16.9
19.1
32.0
34.8
27.9
35.1
34.3
25.8
20.7
21.3
19.9
20.0
20.7
21.7
0.6
0.4
0.9
0.4
0.8
0.7
25.7
20.4
33.5
24.4
24.9
28.0
0.0 20.0 40.0 60.0 80.0 100.0
Total (N=2396)
Femaile (n=1429)
Male (n=967)
University (n=806)
High school (n=866)
Junior high school (n=724)
(%)
Fig. 3. Regenerative medicine to save or improve your life. (A). Q6. Howwould you feel if you were informed by a medical doctor that it was necessary for you to receive a transplant
of someone's organ or tissue to save your life? Statistical signiﬁcance: p < 0.001 vs. sex. (B) Q7. How would you feel if you were informed by a medical doctor that it was necessary
for you to receive a transplant of someone's organ or tissue to improve your inconvenient medical condition? Statistical signiﬁcance: p < 0.001 vs. sex. I would not accept such a
treatment (closed), I would not positively receive such information from a medical doctor (hatched), I would positively receive such information from a medical doctor (dotted), I
would receive such treatment with an organ (tissue) prepared from my cells (open), I would receive such treatment with an organ (tissue) prepared from cells of others (sphere),
and I would receive such treatment with an organ (tissue) prepared from cells of everyone (divot).
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“my cells” than males (p < 0.001). These ﬁndings suggest that
regenerative medicine may be regarded as an accepted medical
treatment for life-threatening and inconvenient medical condi-
tions. However, females were more cautious in the use of
regenerative medicine as a treatment than males.3.4. Interest in the latest medical treatment
Participants reported interest in the development of new
medical technology for untreatable diseases as follows: “I am very
interested in it” (42.8%), “I am interested in it” (46.7%), “I am not
very interested in it” (8.4%), and “I am not interested in it at all”
(2.1%) (data not shown). These ﬁndings reveal that approximately
90% of students are interested in the latest medical treatments.3.5. Regarding ideal and receivable treatments for
incurable diseases
We asked the participants their ideal treatments for incurable
diseases, allowing multiple answers. Treatment with “internal
medicine” and “advanced operation with few burdens” was
selected by 58.0% and 47.8% of participants, respectively (Table 3).
“Medical patches” and “ointments”were selected by approximately
40% of participants. Females preferred these treatments more than
males (p < 0.001). The most infrequently chosen option (2.6%) was
treatment with animal organ (tissue). In contrast, frequently
chosen receivable treatments included “internal medicine” (63.6%),
“ointments” (55.6%) and “medical patches” (55.5%). Females also
preferred these treatments more frequently thanmales (p < 0.001).
Treatment with animal organ (tissue) was selected by 4.0% of
participants. Furthermore, more than 80% of the participants who
Table 3
Ideal treatments willing to be received for incurable diseases (%).
Gender (n) Ideal treatment Receivable treatment Percent receivable treatment of
ideal treatment (%)
Percent receivable treatment of
non-ideal treatment (%)
Male
(967)
Female
(1429)
p Total
(2396)
Male
(967)
Female
(1429)
p Total
(2396)
Treatment with internal medicine 53.8 60.9 *** 58.0 56.8 68.2 *** 63.6 81.4 38.9
Treatment with medical patches 32.4 43.9 *** 39.2 46.8 61.3 *** 55.5 81.9 55.5
Treatment with ointments 31.1 43.9 *** 38.7 46.5 61.7 *** 55.6 82.1 38.8
Treatment with injection 20.7 27.8 *** 24.9 37.7 46.0 *** 42.7 77.2 31.2
Treatment by general operation 14.3 20.6 *** 18.0 28.7 37.0 *** 33.7 70.6 25.6
Treatment by advanced operation
with few burdens
38.9 53.9 *** 47.8 42.1 53.4 *** 48.8 70.2 29.3
Treatment by genome editing 11.4 7.3 ** 8.9 10.7 7.5 ** 8.8 36.9 6.0
Treatment with human organ
(tissue)
9.2 10.2 9.8 13.4 13.4 13.4 49.4 9.5
Treatment with animal organ
(tissue)
3.4 2.0 * 2.6 5.7 2.9 *** 4.0 32.3 3.3
Any method is acceptable 27.4 24.0 25.4 34.7 23.9 *** 28.3 58.1 18.1
Other 2.3 2.9 2.6 2.4 2.4 2.4 33.3 1.6
Statistical signiﬁcance: *p < 0.05, **p < 0.01, ***p < 0.001 vs. sex.
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treatments, regarded them as receivable treatments. In contrast,
the proportions of those selecting treatment with animal organ
(tissue) and by genome editing as receivable treatments were 32.3%
and 36.9%, respectively. Although 9.8% of the participants selected
treatment with human organ (tissue) as ideal, 49.4% of participants
selecting this treatment as ideal also selected it as receivable. This
proportion was higher than those of treatment with animal organ
(tissue) or by genome editing. These ﬁndings suggest that among
new treatment methods, students, especially females, consider
those that are more familiar and less invasive to be ideal.
3.6. Regarding the subject's role as a recipient or donor in
regenerative medicine
When asked whose cells the participants wanted to receive as a
recipient of regenerative medicine, allowing multiple answers,
approximately 60% of participants responded wanting their own
cells, or cells from their family (Table 4). Selection of those options
were signiﬁcantly higher in females than in males (p < 0.001). In
contrast, the proportion of males answering “anyone” was higherTable 4
Role as a recipient and donor in regenerative medicine (%).
Sex (n) Junior high school
Male
(374)
Female
(350)
To
(7
As recipient
I would receive an organ (tissue) prepared from my cells. 54.8 70.0 62
I would receive an organ (tissue) prepared from cells from my
family.
48.4 67.4 57
I would receive an organ (tissue) prepared from cells from my
friend.
25.9 24.6 25
I would receive an organ (tissue) prepared from cells of a person
whom the hospital and specialized agencies chose.
34.8 30.9 32
I would receive an organ (tissue) prepared from cells from anyone. 16.8 10.3 13
I would not receive an organ (tissue). 5.9 3.7 4.8
As donor
I would donate my cells to use for me. 44.1 48.3 46
I would donate my cells to use for my family. 48.9 55.4 52
I would donate my cells to use for my friend. 37.7 36.6 37
I would donate my cells to use for a person whom the hospital and
specialized agencies chose.
20.6 21.7 21
I would donate my cells to use for anyone. 41.2 41.4 41
I would not donate my cells. 3.7 2.3 3.0
Statistical signiﬁcance: #p < 0.05, ##p < 0.01, ###p < 0.001 vs. kinds of schools; **p < 0.0than that of females (p < 0.001). The proportion of participants who
selected “person whom the hospital and specialized agency chose”
was 38.6%. As a donor, “for family”, “for anyone”, and “for me”were
selected by 48.0%, 45.7%, and 43.2% of participants, respectively
(Table 4). The proportions of females who answered “for me” and
“for family” were higher than that of males (p < 0.001). There was
no signiﬁcant difference in those who answered “for anyone” be-
tween males and females. Participants who answered “person
whom the hospital and specialized agency chose” increased in an
age-dependent manner (p < 0.001). These ﬁndings suggest that
regarding organ or tissue donation for regenerative medicine,
students focused more on the characteristics of the donors.
3.7. Cell stocking
We asked the participants their opinion on the cryopreservation
of their own cells, allowing multiple answers. As a result, 46.6%
wanted to stock their cells “for family”, and a similar proportion
selected “for me” (46.0%) (Fig. 4). The proportion of participants
who answered “for everyone”was 34.0%. Females preferred “for me
(p < 0.05)” and “for family (p < 0.001)” more than males. TheHigh school University Sex Total
(2396)
p
tal
24)
Male
(311)
Female
(555)
Total
(866)
Male
(280)
Female
(526)
Total
(806)
Male
(967)
Female
(1429)
.2 46.0 67.2 59.6 46.4 68.8 61.0 49.5 68.5 60.9 ***
.6 41.2 64.7 56.2 45.7 66.5 59.3 45.4 66.0 57.7 ***
.3 21.2 28.1 25.6 25.4 25.9 25.7 24.3 26.4 25.5
.9 34.4 41.3 38.8 43.9 43.2 43.4 37.3 39.4 38.6 ###
.7 22.8 12.3 16.1 26.8 13.9 18.4 21.7 12.3 16.1 ***
3.2 1.6 2.2 3.6 2.5 2.9 4.3 2.4 3.2 ##,
***
.1 31.5 45.6 40.5 34.6 48.1 43.4 37.3 47.2 43.2 ***
.1 37.0 51.2 46.1 36.8 51.7 46.5 41.7 52.3 48.0 #,***
.2 26.0 34.6 31.5 30.0 31.9 31.3 31.7 34.1 33.1 #
.1 22.5 29.7 27.1 28.6 33.5 31.8 23.6 29.1 26.9 ###,
**
.3 46.3 48.3 47.6 51.4 45.6 47.6 45.8 45.6 45.7 #
2.6 1.6 2.0 1.8 0.8 1.1 2.8 1.5 2.0 #
1, ***p < 0.001 vs. sex.
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*
Fig. 4. Cell stock. I want to stock my cells for me (closed), for my family (hatched), for my friends (dotted), for the people the hospital and specialized agencies choose (open), for
everyone (sphere), and I don't want to stock my cells (divot). Statistical signiﬁcance: ###p < 0.001 vs. kinds of schools; *p < 0.05, ***p < 0.001 vs. sex.
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their own cells was 11.6%. The proportion of participants who
wanted to stock cells for people whom the hospital and specialized
agencies chose signiﬁcantly increased in an age-dependent manner
(p < 0.001). Furthermore, regarding use of cryopreserved cells as a
medical resource, the proportions of participants who answered “I
want to stock my cells for the people whom the hospital and
specialized agencies chose” and “I want to stock my cells for
everyone” were 19.3% (n ¼ 463) and 34.0% (n ¼ 814), respectively.
Because 148 participants answered “yes” to both cases, the total
number of participants answering “yes” to either option was 1129
(47.1%). These results reveal that approximately 90% of students had
a positive view on the storage of their own cells. Students who had
a positive viewon the storage of iPS cells for use in amedical iPS cell
stock was approximately 50%.
3.8. Interests and anxieties regarding iPS cells and
regenerative medicine
We asked the participants regarding their interests and anxi-
eties of iPS cells and regenerative medicine, allowing multiple an-
swers. As shown in Tables 5 and 6, most participants selected sideeffects, safety of the organ or tissue transplanted, method of
transplantation, and treatment cost, as both points of interest and
anxiety. Interest and anxiety of these factors were signiﬁcantly
higher in females than in males (Tables 5 and 6). Thus, most stu-
dents were interested and anxious regarding the side effects, safety,
and treatment costs of regenerative medicine.
3.9. Expectation of the establishment of iPS cell and regenerative
medicine usage
Expectations of the establishment of iPS cell and regenerative
medicine usagewas as follows: “I highly expect it” (55.9%), “I expect
it” (39.1%), “I don't really expect it” (4.0%), and “I don't expect it at
all” (1.0%) (data not shown). These ﬁndings reveal that 95.0% of the
participants expected the establishment of iPS cell and regenerative
medicine usage.
3.10. Involvement in work with iPS cells or regenerative medicine in
the future
We asked whether participants foresaw involvement in work
with iPS cells and regenerative medicine in the future. Responses
Table 5
Points of interest regarding iPS cells and regenerative medicine (%).
Sex (n) Junior high school High school University Sex Total
(2396)
p
Male
(374)
Female
(350)
Total
(724)
Male
(311)
Female
(555)
Total
(866)
Male
(280)
Female
(526)
Total
(806)
Male
(967)
Female
(1429)
iPS cells 55.9 56.0 55.9 45.0 44.0 44.3 53.6 48.7 50.4 51.7 48.6 49.9 ###
Regenerative medicine 46.8 46.9 46.8 39.5 48.3 45.2 51.1 52.7 52.1 45.6 49.6 48.0 #
Target diseases 46.0 60.0 52.8 44.7 63.8 56.9 47.5 67.5 60.5 45.9 64.3 56.9 ##,***
Progress of research 38.0 24.0 31.2 32.5 25.4 27.9 47.1 34.2 38.7 38.8 28.3 32.6 ###,***
Research institutes and
universities
16.0 9.4 12.8 11.9 8.1 9.5 14.3 9.5 11.2 14.2 9.0 11.1 ###,***
Time of realization 29.7 28.9 29.3 30.5 30.5 30.5 35.4 38.6 37.5 31.5 33.1 32.5
Methods of medical treatment 44.7 53.4 48.9 36.7 50.8 45.7 35.4 54.2 47.6 39.3 52.8 47.3 ***
Treatment cost 47.1 45.7 46.4 41.5 51.9 48.2 51.8 63.1 59.2 46.6 54.5 51.3 ###,***
Duration of treatment 28.6 30.9 29.7 24.4 29.4 27.6 29.3 35.6 33.4 27.4 32.1 30.2 #,*
Effectiveness 40.1 46.0 43.0 34.4 41.6 39.0 49.6 57.4 54.7 41.0 48.6 45.5 ###,***
Side effects 54.0 58.0 55.9 51.8 60.5 57.4 62.5 73.2 69.5 55.8 64.5 61.0 ###,***
Safety of organ or tissue
transplanted
44.7 53.1 48.8 37.6 56.0 49.4 48.6 62.4 57.6 43.5 57.7 52.0 ###,***
Safety of method of
transplantation
44.7 51.1 47.8 38.9 51.2 46.8 47.5 55.3 52.6 43.6 52.7 49.0 #,***
How to participate in the
research
7.8 6.0 6.9 2.3 1.3 1.6 4.6 3.0 3.6 5.1 3.1 3.9 ###,**
Others 4.3 2.3 3.3 1.6 0.2 0.7 2.1 1.1 1.5 2.8 1.0 1.8 ###,**
Statistical signiﬁcance: #p < 0.05, ##p < 0.01, ###p < 0.001 vs. kinds of schools; *p < 0.05, **p < 0.01, ***p < 0.001 vs. sex.
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likely” (46.3%), and “Extremely unlikely” (18.0%) (Fig. 5). There was
signiﬁcant difference among kinds of schools (p < 0.05), and be-
tweenmales and females (p < 0.001). These ﬁndings suggest varied
interests in career paths among the students.
3.11. Need of education on iPS cells and regenerative medicine
We asked the participants whether they thought education for
better understanding of iPS cells and regenerative medicine was
necessary. As shown in Fig. 6A, “strongly agree” and “agree” were
selected by 19.7% and 54.2% of the participants, respectively.
Taken together, 73.9% thought that education was necessary.
There was signiﬁcant difference between males and females
(p < 0.001) and kinds of schools (p < 0.001). The necessary of
education for the public increased in an age-dependent manner
(p < 0.001). On the other hand, 75.6% of participants wanted toTable 6
Anxiety regarding iPS cells and regenerative medicine (%).
Sex (n) Junior high school High school
Male
(374)
Female
(350)
Total
(724)
Male
(311)
Fema
(555)
Whether target disease is overcome 57.0 63.1 59.9 46.3 56.9
Progress of research 15.0 9.4 12.3 15.8 7.9
Time of realization 21.7 15.4 18.6 16.4 16.8
Methods of medical treatment 31.0 34.9 32.9 22.5 30.3
Treatment cost 51.6 55.7 53.6 47.3 61.4
Duration of treatment 21.9 26.0 23.9 18.3 23.1
Effectiveness 24.9 28.9 26.8 21.2 30.6
Side effects 64.7 72.0 68.2 63.0 73.5
Safety of organ or tissue transplanted 48.1 59.1 53.5 48.1 59.1
Safety of method of transplantation 46.3 59.4 52.6 43.1 57.5
Whether I can understand the method
when I am treated
11.2 14.3 12.7 10.9 13.0
Whether I can determined to be treated 18.7 25.4 22.0 14.1 21.1
Whether prejudice would occur in our
society
18.4 19.4 18.9 12.2 12.1
Whether bullying would occur in our
school
15.0 15.1 15.1 7.4 4.0
Others 3.5 1.1 2.3 1.9 0.7
Statistical signiﬁcance: ###p < 0.001 vs. kinds of schools; *p < 0.05, **p < 0.01, ***p < 0.0receive education for improving their understanding of iPS cells
and regenerative medicine (Fig. 6B). Females wanted to undergo
the education than males (p < 0.001), and it increased in an age-
dependent manner (p < 0.001). Thus, more than 70% of students
supported education for the understanding of iPS cells and
regenerative medicine.
4. Discussion
In this study, we showed that more than 80% of students had
recognition of iPS cells and regenerative medicine, and approxi-
mately the same number of students reported interest in and
support of regenerative medicine. Ninety-ﬁve percent expected
the establishment of iPS cell and regenerative medicine usage.
However, many students reported having concerns of the side
effects, safety, and treatment costs of regenerative medicine, and
supported education for improving the understanding of iPS cellsUniversity Sex Total
(2396)
p
le Total
(866)
Male
(280)
Female
(526)
Total
(806)
Male
(967)
Female
(1429)
53.1 42.5 52.7 49.1 49.3 56.9 53.8 ###,***
10.7 15.4 7.8 10.4 15.3 8.3 11.1 ***
16.6 19.6 13.5 15.6 19.3 15.3 16.9 **
27.5 19.3 26.6 24.1 24.8 30.1 28.0 ###,**
56.4 49.6 58.6 55.5 49.6 59.0 55.2 ***
21.4 18.2 23.4 21.6 19.6 23.9 22.2 *
27.3 21.2 30.6 35.5 24.9 33.2 29.9 ###,***
69.7 70.7 81.9 78.0 66.0 76.2 72.1 ###,***
51.7 47.9 68.1 61.0 44.7 62.6 55.4 ###,***
52.3 40.7 65.0 56.6 43.6 60.7 53.8 ***
12.2 10.7 15.0 13.5 11.0 14.1 12.8 *
18.6 17.5 24.7 22.2 16.9 23.5 20.8 ***
12.1 20.0 22.2 21.5 16.9 17.6 17.3 ###
5.2 11.1 12.2 11.8 11.5 9.7 10.4 ###
1.2 2.9 1.9 2.2 2.8 1.3 1.9 **
01 vs. sex.
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Fig. 5. Involvement in work with iPS cells or regenerative medicine in the future. Extremely likely (closed), likely (hatched), unlikely (dotted), and extremely unlikely (open).
Statistical signiﬁcance: p < 0.05 vs. kinds of schools; p < 0.001 vs. sex.
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students supported storing iPS cells for use in regenerative
medicine.
Shineha et al. reported in 2010 that recognition of iPS cells and
regenerative medicine by Japanese public was 73.7% and 87.3%,
respectively [34]. In this study, we showed 94.9% and 83.4% of
students recognized iPS cells and regenerative medicine, respec-
tively (Table 2), suggesting recognition of iPS cells was increased
compared with report by Shineha et al. The increase in the recog-
nition of iPS cells in students might result fromwinning Nobel Prize
of Professor Yamanaka. Concerning the need of regenerative med-
icine realization, the proportion of need of the realization (Fig. 2)
was similar to the proportion of reported by Shineha et al. [34].
Furthermore, 21.6% said that they would like to cooperate by of-
fering cells and/or blood, and 69.4% would like to wait and see the
results of further research [34]. In contrast, our study indicated that
students who had a positive view on the storage of iPS cells for use
in a medical iPS cell stock was approximately 50%, suggesting that
cooperative people increased. More than 70% of students thought
that education was necessary and wanted to receive education for
improving their understanding of iPS cells and regenerative med-
icine (Fig. 6), whereas approximately 20% would like to search for
information through internet, books or seminars [34]. Therefore,
our study suggests that students are positive to realize regenerative
medicine.
It is suggested that thinking patterns differ between males and
females [35,36]. In the present study, signiﬁcant sex differences
were observed. Males reported better understanding of iPS cells
and regenerative medicine (Table 2), and were highly interested in
them (Fig. 1). More males reported support of regenerative medi-
cine (Fig. 2) compared with females. Furthermore, males have in-
terests and anxieties about sciences such as “progress of research”
and “research institutes and universities” than females (Tables 5
and 6), and preferred “organ (tissue) prepared from cells of
everyone” in regenerative medicine to save or improve own life
(Fig. 3). On the other hand, more females reported to be interested
in and anxious regarding the “side effects”, “safety”, and “treatment
costs” (Tables 5 and 6), wanted to undergo the education for iPS
cells and regenerative medicine (Fig. 6B), and considered more
familiar and less invasive treatments (Table 3). Furthermore,females would make a decision in consultation with a medical
doctor (Fig. 3). Our data suggests that there are sex differences in
regenerative medicine. Males might view iPS cells and regenerative
medicine as one of the new technologies than females. However,
femalesmight think them as one of the realistic medical treatments
than males.
Some textbooks of junior high schools or high schools describe
regarding iPS cells and regenerative medicine. However, there are
in topic and development sections, and the words such as regen-
erative medicine and iPS cells are not listed in a course of study in
Japan. Therefore, it depends on the publishing company whether
contents about regenerative medicine and iPS cells are listed in
textbooks. However, in this study, we showed that more than 80%
of the students recognized iPS cells and regenerative medicine, and
approximately 50e60% knew both words and subjects, and the
recognition increased in an age-dependent manner (Table 2).
Although, the knowledge about the regenerative medicine of the
public was based on information obtained from the media partic-
ularly TV [33,34], education in schools might also contribute the
knowledge. According to a course of study in Japan, students learn
some words to understand regenerative medicine and iPS cells, for
example, “cell” in the science of seventh grader and “gene” in the
science of ninth grader. Students who answered “personwhom the
hospital and specialized agency chose” as both recipient and donor,
increased in an age-dependentmanner (p < 0.001, Table 4), and “for
the people the hospital and specialized agencies choose” in cell
stock (p < 0.001, Fig. 4) increased an age-dependent manner. This
tendency might result from learning “organ transplantation” in the
health of eleventh grader and the basic biology in high school.
Therefore, it is thought that students deepen the knowledge of
regenerative medicine through the learning various subjects in
schools.
In the present study, we reported that many students support
development of regenerative medicine, and those with negative
opinions were few (Figs. 1e3 and Table 4), suggesting that students
may consider the use of regenerative medicine as a possible medical
treatment if needed in the future. When organs or tissues prepared
from iPS cells are transplanted to the recipient, it is important tomatch
at least partially the HLA type, such as HLA-A, B, and DR, between the
donor and recipient to prevent graft rejection. Okita et al. estimated
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Fig. 6. Need of education of iPS cells and regenerative medicine. (A). Q18. Do you think that education for the understanding of iPS cells and regenerative medicine is necessary for
the public? Statistical signiﬁcance: p < 0.001 vs. kinds of schools; p < 0.001 vs. sex. (B) Q19: Do you want to undergo education for improving your understanding of iPS cells and
regenerative medicine? Statistical signiﬁcance: p < 0.001 vs. kinds of schools; p < 0.001 vs. sex. Strongly agree (closed), agree (hatched), disagree (dotted), and strongly disagree
(open).
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vide a match for 90% of the Japanese population, but would require
160,000 individuals for construction [10]. We reported that approxi-
mately 50%of students supportedmedical storage of iPS cells for use in
regenerative medicine. The present results also suggest that the
establishment of the 140 HLA-homozygous lines may be performed
smoothly in Japan.However, as adonor, it shouldbenoted that support
of iPS cell storage for use in regenerative medicine was only approxi-
mately 50%, whereas opposition was approximately 10% (Fig. 4). In
contrast, as shown in Table 4, many students reported a preference of
receiving regenerative medicine treatment using their own cells
(60.9%), or cells collected from their family (57.7%) or someone chosen
by the hospital and specialized agency (38.6%), suggesting that these
students preferred an organ or tissue from a source perceived as being
highly reliable. Possible ethical problems and the future direction of
stem cell therapy, such as iPS cells therapy, have been described by
Kanemura [37]. Regarding cell transfer for regenerative medicine,
improvement of understanding of as both donors and recipients may
promote recognition and satisfaction of this therapy.QOL of the public including patients might be improved by both
medical approach and social approach. Both approaches are
important for the public including patients to improve the QOL in
community through understanding of regenerative medicine. As
shown in Table 6, anxieties of possible side effects and safety may
be a result of the students' exposure to reports of genemisinsertion
and tumor generation [4,38,39] by the mass media following the
establishment of iPS cells. Therefore, transmission of information
on the scientiﬁc and medical progress in technology is important
for improvement of student's understanding. Because target dis-
eases (56.9%) and treatment cost (51.3%) were frequently selected
as points of interest (Table 5), as well as students' general opinion as
shown in Fig. 2, it is thought that students recognize the impor-
tance of regenerative medicine as a medical care. Regarding edu-
cation, more than 70% of students supported its need (Fig. 6). Some
students reported having concerns of possible prejudice and
bullying in the community (Table 6). The public most likely obtains
information regarding iPS cells and regenerative medicine via
media including TV [33,34]. However, students reported the desire
K. Ishihara et al. / Regenerative Therapy 5 (2016) 96e106106to learn more of those topics (Fig. 6), suggesting that students
prefer the acquisition of comprehensive knowledge compared with
fragmentary information provided by TV. Furthermore, it is
important for students to participate in programs for science
communication at university and museum. The organization such
as the California Institute for Regenerative Medicine (CIRM) is also
one of the participation. Now that clinical studies have been star-
ted, it may be time to promote educational programs for the stu-
dents to facilitate individual, educated consideration of
regenerative medicine as an alternative in medical care, together
with understanding of the road map for iPS cells and regenerative
medicine presented by MEXT.
In this study, we applied the judgmental sampling. Our sam-
pling was depended on a judgment of principal in each school.
Therefore, there might be included a selection bias. Further inves-
tigation is necessary for the public understanding of regenerative
medicine through social approach with medical approach.
In conclusion, we described the recognition of, interest in, and
understanding of iPS cells and regenerative medicine in junior high
school, senior high school, and university students. We suggest that
social approach, in addition to medical approach, is necessary to
improve the QOL of patient through further understanding of
regenerative medicine by students, by supporting spread of infor-
mation and education.
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